Back to Search
Start Over
Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
- Source :
-
Journal of chemotherapy (Florence, Italy) [J Chemother] 1991 Oct; Vol. 3 (5), pp. 321-7. - Publication Year :
- 1991
-
Abstract
- A total of 124 patients with lower respiratory tract (44) or urinary tract infections (80) were enrolled in an open, multicenter study to evaluate the efficacy and tolerability of sulbactam/ampicillin, administered at the dosage of 3 g/die by intramuscular route. Pretreatment pathogens from patients with lower respiratory tract infections included: Streptococcus alpha-haemolyticus in 8 cases, Streptococcus beta-haemolyticus in 2 cases, Staphylococcus albus in 7 cases, Haemophilus influenzae in 7 cases, Staphylococcus aureus in 6 cases, Klebsiella oxytoca in 5 cases, Staphylococcus epidermidis in 3 cases, Streptococcus pneumoniae in 3 cases, Escherichia coli in 2 cases; in one subject (2.75%), no microorganisms were isolated. In vitro, 36 isolates (84%) were sensitive to SA and 7 (16%) were resistant. At the end of therapy, all the causative pathogens sensitive to sulbactam/ampicillin were eliminated. In patients with urinary tract infections, pretreatment pathogens were: E. coli in 40 cases, S. albus in 16 cases, Proteus mirabilis in 8 cases, Enterobacter agglomerans in 6 cases, Proteus vulgaris in 3 cases, Streptococcus faecalis in 3 cases, Streptococcus liquefaciens in 2 cases, Pseudomonas aeruginosa in 2 cases. In vitro, 64 isolates (80%) were sensitive to sulbactam/ampicillin and 16 (20%) were resistant. At the end of therapy, 63 out of the 64 pathogens sensitive to sulbactam/ampicillin were eliminated; in one case the therapy was interrupted due to adverse effect. Clinical efficacy: in subjects with lower respiratory tract infections, sulbactam/ampicillin cured 32 patients (72.72%) and ameliorated the clinical status of 8 patients (18.18%); efficacy rate: 90.9%).(ABSTRACT TRUNCATED AT 250 WORDS)
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Ampicillin administration & dosage
Ampicillin adverse effects
Culture Media
Drug Synergism
Drug Therapy, Combination administration & dosage
Drug Therapy, Combination adverse effects
Drug Therapy, Combination therapeutic use
Female
Gram-Negative Bacterial Infections drug therapy
Humans
Male
Middle Aged
Respiratory Tract Infections microbiology
Staphylococcal Infections drug therapy
Streptococcal Infections drug therapy
Sulbactam administration & dosage
Sulbactam adverse effects
Urinary Tract Infections microbiology
beta-Lactamases metabolism
Ampicillin therapeutic use
Respiratory Tract Infections drug therapy
Sulbactam therapeutic use
Urinary Tract Infections drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1120-009X
- Volume :
- 3
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of chemotherapy (Florence, Italy)
- Publication Type :
- Academic Journal
- Accession number :
- 1809811
- Full Text :
- https://doi.org/10.1080/1120009x.1991.11739113